Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
| CAPS Rating |
|
|---|---|
| Open | $11.02 |
| Previous Close | $11.13 |
| Daily Range | $10.75 - $11.08 |
| 52-Week Range | $2.67 - $15.25 |
| Market Cap | $1.05B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,569,771 |
| Average Daily Volume | 0 |
IDIX
VS S&P 500 (SPY)
How do you think IDIX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
IDIX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
IDIX News and Commentary
- Why Did My Stock Just Die? – The Motley Fool
- Company News for February 6, 2012 - Corporate Summary – NASDAQ
- There’s no Stopping Gilead Sciences – Blogs @ The Motley Fool
- Idenix Pharmaceuticals Shares Dropped: What You Need to Know – The Motley Fool
- Gilead Sciences Shares Surged: What You Need to Know – The Motley Fool
- UPDATE: Idenix Says FDA Partial Hold On Hepatitis C Drug Lifted – SmartMoney
- Celldex has potential to have a blockbuster Breast Cancer Drug – Blog at The Motley Fool
- Idenix Pharmaceuticals Shares Plunged Temporarily: What You Need to Know – The Motley Fool
- Biotech Investors Confident: Industry Sees Big VC Spending in 2011 – The Motley Fool
- Investing 101: Hedge Funds Love These High-Volume Stocks Reaching New Highs – The Motley Fool
- Could These Huge Health-Care Buyouts Continue? – The Motley Fool
- Momentum Stocks: A Simple Momentum Strategy That Lowers Your Risk – The Motley Fool
- 3 Stocks Stopping the Presses – The Motley Fool
- Inhibitex Auction Shows Battle for Hepatitis Drugs – Minyanville
- 5 of Last Week's Biggest Winners – The Motley Fool
- The Sector That's Delivering 2012's Biggest Winners – The Motley Fool
- 3 Stocks to Get on Your Watchlist – The Motley Fool
- Optimism and Buyouts Keep Markets Humming – The Motley Fool
- Idenix Pharmaceuticals Shares Skyrocketed Again: What You Need to Know – The Motley Fool
- Call me Lucky.. Monster gains in ACHN & IDIX – Blog at The Motley Fool
RSS Headlines
Fool UK
